394 related articles for article (PubMed ID: 1704412)
1. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
Forrester AJ; Sullivan V; Simmons A; Blacklaws BA; Smith GL; Nash AA; Minson AC
J Gen Virol; 1991 Feb; 72 ( Pt 2)():369-75. PubMed ID: 1704412
[TBL] [Abstract][Full Text] [Related]
2. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice.
Cremer KJ; Mackett M; Wohlenberg C; Notkins AL; Moss B
Science; 1985 May; 228(4700):737-40. PubMed ID: 2986288
[TBL] [Abstract][Full Text] [Related]
3. Baculovirus-expressed glycoprotein H of herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge.
Ghiasi H; Kaiwar R; Nesburn AB; Wechsler SL
J Gen Virol; 1992 Mar; 73 ( Pt 3)():719-22. PubMed ID: 1312127
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody.
Sullivan V; Smith GL
J Gen Virol; 1987 Oct; 68 ( Pt 10)():2587-98. PubMed ID: 2822841
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants.
Blacklaws BA; Krishna S; Minson AC; Nash AA
Virology; 1990 Aug; 177(2):727-36. PubMed ID: 2164732
[TBL] [Abstract][Full Text] [Related]
6. Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies.
Liu DX; Gompels UA; Foa-Tomasi L; Campadelli-Fiume G
Virology; 1993 Nov; 197(1):12-22. PubMed ID: 7692666
[TBL] [Abstract][Full Text] [Related]
7. Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity.
Allen EM; Weir JP; Martin S; Mercadal C; Rouse BT
Viral Immunol; 1990; 3(3):207-15. PubMed ID: 2175194
[TBL] [Abstract][Full Text] [Related]
8. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection.
Martin S; Rouse BT
J Immunol; 1987 May; 138(10):3431-7. PubMed ID: 3033075
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D.
Aurelian L; Smith CC; Wachsman M; Paoletti E
Rev Infect Dis; 1991; 13 Suppl 11():S924-34. PubMed ID: 1664130
[TBL] [Abstract][Full Text] [Related]
10. Analysis of protective immune responses to the glycoprotein H-glycoprotein L complex of herpes simplex virus type 1.
Browne H; Baxter V; Minson T
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2813-7. PubMed ID: 8277292
[TBL] [Abstract][Full Text] [Related]
11. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
Peng T; Ponce-de-Leon M; Jiang H; Dubin G; Lubinski JM; Eisenberg RJ; Cohen GH
J Virol; 1998 Jan; 72(1):65-72. PubMed ID: 9420201
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins.
Martin S; Cantin E; Rouse BT
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1359-70. PubMed ID: 2543783
[TBL] [Abstract][Full Text] [Related]
13. Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge.
Weir JP; Bennett M; Allen EM; Elkins KL; Martin S; Rouse BT
J Gen Virol; 1989 Oct; 70 ( Pt 10)():2587-94. PubMed ID: 2794972
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
15. Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.
Rooney JF; Wohlenberg C; Cremer KJ; Moss B; Notkins AL
J Virol; 1988 May; 62(5):1530-4. PubMed ID: 2833606
[TBL] [Abstract][Full Text] [Related]
16. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
Roberts PL; Duncan BE; Raybould TJ; Watson DH
J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
[TBL] [Abstract][Full Text] [Related]
17. The herpes simplex virus type 1 US7 gene product is a 66K glycoprotein and is a target for complement-dependent virus neutralization.
Sullivan V; Smith GL
J Gen Virol; 1988 Apr; 69 ( Pt 4)():859-67. PubMed ID: 2833569
[TBL] [Abstract][Full Text] [Related]
18. Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts.
Krishna S; Blacklaws BA; Overton HA; Bishop DH; Nash AA
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1805-14. PubMed ID: 2544667
[TBL] [Abstract][Full Text] [Related]
19. Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease.
Wachsman M; Aurelian L; Smith CC; Perkus ME; Paoletti E
J Infect Dis; 1989 Apr; 159(4):625-34. PubMed ID: 2538519
[TBL] [Abstract][Full Text] [Related]
20. Antigen-presenting capacity of epidermal cells infected with vaccinia virus recombinants containing the herpes simplex virus glycoprotein D, and protective immunity.
Wachsman M; Luo JH; Aurelian L; Perkus ME; Paoletti E
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2513-20. PubMed ID: 2550579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
